Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan:126:125-131.
doi: 10.1016/j.ijid.2022.11.018. Epub 2022 Nov 17.

COVID-19 and diarrhea: putative mechanisms and management

Rifat Tasnim Juthi  1 , Saiful Arefeen Sazed  1 , Monira Sarmin  2 , Rashidul Haque  1 , Mohammad Shafiul Alam  3
Affiliations
Review

COVID-19 and diarrhea: putative mechanisms and management

Rifat Tasnim Juthi et al. Int J Infect Dis. 2023 Jan.

Abstract

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19), has recently posed a threat to global health by spreading at a high rate and taking millions of lives worldwide. Along with the respiratory symptoms, there are gastrointestinal manifestations and one of the most common gastrointestinal symptoms is diarrhea which is seen in a significant percentage of COVID-19 patients.

Literature review: Several studies have shown the plausible correlation between overexpressed angiotensin converting enzyme 2 (ACE2) in enterocytes and SARS-CoV-2, as ACE2 is the only known receptor for the virus entry. Along with the dysregulated ACE2, there are other contributing factors such as gut microbiome dysbiosis, adverse effects of antiviral and antibiotics for treating infections and inflammatory response to SARS-CoV-2 which bring about increased permeability of gut cells and subsequent occurrence of diarrhea. Few studies found that the SARS-CoV-2 is capable of damaging liver cells too. No single effective treatment option is available.

Limitations: Confirmed pathophysiology is still unavailable. Studies regarding global population are also insufficient.

Conclusion: In this review, based on the previous works and literature, we summarized the putative molecular pathophysiology of COVID-19 associated diarrhea, concomitant complications and the standard practices of management of diarrhea and hepatic manifestations in international setups.

Keywords: Angiotensin-converting enzyme-2; Antibiotic-associated diarrhea; COVID-19; Diarrhea; Diarrhea management; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors have no competing interests to declare.

Figures

Figure 1
Figure 1
Partial mechanisms of COVID-19-associated diarrhea. SARS-CoV-2 binds to ACE2 receptor and the S protein of viral envelop is cleaved into S1 and S2 (1). Activated S2 leads to the fusion of viral membrane and host cell membrane (2 & 3). Entry of the virus into the host cell causes ionic imbalance in the host contributing to a leaky gut. This figure was partially adapted from ‘Mechanism of SARS-CoV-2 Viral Entry’ by BioRender.com (2022) and retrieved from https://app.biorender.com/biorender-templates. ACE2: Angiotensin-converting enzyme; CaCC: Ca2+ activated Cl− Channel; CFTR: CF transmembrane conductance regulator; NHE3: Na+-H+ exchanger 3; S, spike.
Figure 2
Figure 2
Mechanisms involved in COVID-19-associated diarrhea. SARS-CoV-2 enters into a host cell by ACE2 receptor, where it disrupts the B0AT/ACE2 absorption pathway and then interrupts the activation of mTOR resulting in the reduction of antimicrobial peptide production. Altogether, these affect the normal gut microbiome contributing to inflammatory cytokine production. This figure was partially generated by Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license. ACE2: angiotensin-converting enzyme; B0AT, broad neutral amino acid transporter; mTOR, mammalian target of rapamycin.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Abdel-Naser MB. COVID-19 pandemic and teledermatology in low-income regions. Edorium J Dermatol. 2021;3 10000402MA2021.
    1. Abraham B, Sellin JH. Drug-induced diarrhea. Curr Gastroenterol Rep. 2007;9:365–372. - PubMed
    1. Aksoy H, Karadag AS, Wollina U. Angiotensin II receptors: impact for COVID-19 severity. Dermatol Ther. 2020;33:e13989. - PMC - PubMed
    1. Andring JT, McKenna R, Stevens BR. Amino acid transporter B0AT1 influence on ADAM17 interactions with SARS-CoV-2 receptor ACE2 putatively expressed in intestine, kidney, and cardiomyocytes. bioRxiv. 2020:361873. doi: 10.1101/2020.10.30.361873. - DOI
    1. Barrett KE, Keely SJ. Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects. Annu Rev Physiol. 2000;62:535–572. - PubMed

Substances